Growth hormone treatment in Noonan syndrome.

T Tanaka
Author Information
  1. T Tanaka: Department of Endocrinology and Metabolism, National Children's Medical Research Center, Tokyo, Japan.

Abstract

Growth responses to growth hormone (GH) treatment in Noonan syndrome are compared with those in short children with the other growth disorders. The responses in Noonan syndrome are much less than those in children with GH deficiency, a little less than those in children with non-endocrine short stature and almost the same as those in children with Turner syndrome. As it is speculated that GH induces puberty earlier that expected in Noonan Syndrome, the efficiency of GH treatment for final height in Noonan syndrome is not promising.

MeSH Term

Adolescent
Adult
Body Height
Child
Child, Preschool
Dwarfism
Female
Growth Hormone
Humans
Infant
Japan
Male
Noonan Syndrome
Prognosis
Puberty

Chemicals

Growth Hormone

Word Cloud

Created with Highcharts 10.0.0NoonansyndromeGHchildrentreatmentGrowthresponsesgrowthhormoneshortlesscompareddisordersmuchdeficiencylittlenon-endocrinestaturealmostTurnerspeculatedinducespubertyearlierexpectedSyndromeefficiencyfinalheightpromising

Similar Articles

Cited By